ArticlePediatric rheumatology online journal2024
Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis, the first Chinese experience.
Lingzhi Qiu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it